typ : |
noviny |
internetový odkaz : |
https://ijpc.com/Abstracts/Abstract.cfm?ABS=4526 |
|
výzkumné týmy : |
Rochester - Wegmans School of Pharmacy |
Autor : |
Zhao F, Dave V.S, Mar M, Perri J. |
titul : |
Formulation and Stability Study of Eslicarbazepine Acetate Oral Suspensions for Extemporaneous Compounding. |
Référence : |
Int J Pharm Compound 22,5:433-439 2018 |
|
Úroveň důkazu : |
|
Fyzikální stabilita : |
|
chemická stabilita : |
|
jiné metody : |
|
Komentáře : |
|
Seznamy
Eslicarbazepine acetate
|
|
|
|
|
1200 mg Aptiom® |
OraPlus® / OraSweet® (1:1) |
>> 30 mL |
|
2-8°C |
|
63 |
|
|
|
|
|
|
1200 mg Aptiom® |
OraPlus® / OraSweet SF® (1:1) |
>> 30 mL |
|
2-8°C |
|
63 |
|
|
|
|
|
|
1200 mg Aptiom® |
OraPlus® / OraSweet® (1:1) |
>> 30 mL |
|
25°C |
|
63 |
|
|
|
|
|
|
1200 mg Aptiom® |
OraPlus® / OraSweet SF® (1:1) |
>> 30 mL |
|
25°C |
|
63 |
|
|
|
|
|